BioMarin Pharmaceutical Inc. is a world leader in developing and commercializing innovative therapies for rare genetic diseases. As pioneers of breakthrough medicines, we focus on patients facing rare and sometimes fatal conditions who have limited, if any, treatment options. With seven products on the market and multiple clinical and pre-clinical product candidates, BioMarin is dedicated to providing innovative therapeutics to patients with serious unmet medical needs.